Reply to: Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtíšek et al
Language English Country Germany Media print-electronic
Document type Letter, Comment
PubMed
34292349
DOI
10.1007/s00066-021-01818-w
PII: 10.1007/s00066-021-01818-w
Knihovny.cz E-resources
- MeSH
- Chemoradiotherapy MeSH
- Humans MeSH
- Magnetic Resonance Imaging MeSH
- Uterine Cervical Neoplasms * diagnostic imaging therapy MeSH
- Positron-Emission Tomography MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Letter MeSH
- Comment MeSH
See more in PubMed
Vojtíšek R, Baxa J, Kovářová P et al (2021) Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. Strahlenther Onkol 197(6):494–504 DOI
Bhatla N, Berek JS, Cuello Fredes M et al (2019) Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet 145(1):129–135 DOI
Olawaiye AB, Baker TP, Washington MK, Mutch DG (2021) The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. CA Cancer J Clin 71(4):287–298 DOI
Amin MB, Edge SB, Greene FL (2017) AJCC cancer staging manual, 8th edn. Springer, New York DOI
Onal C, Reyhan M, Guler OC, Yapar AF (2014) Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy. Eur J Nucl Med Mol Imaging 41(7):1336–1342 DOI
Grueneisen J, Schaarschmidt BM, Heubner M et al (2015) Integrated PET/MRI for whole-body staging of patients with primary cervical cancer: preliminary results. Eur J Nucl Med Mol Imaging 42(12):1814–1824 DOI
